Necroptosis in asthma: a critical driver of immune dysregulation and airway remodeling - Summary - MDSpire

Necroptosis in asthma: a critical driver of immune dysregulation and airway remodeling

  • By

  • Feng-Xian Ni

  • Shao-Cong Ren

  • Jie Hu

  • Pei-Sheng Chen

  • Hui-Hui Chen

  • Dong-Hui Huang

  • Ze-Bo Jiang

  • June 23, 2026

  • 0 min

Share

Objective:

To explore the role of necroptosis in asthma pathophysiology and its implications for immune dysfunction and airway remodeling.

Approach:
    Key Findings:
    • Necroptosis is an active pathogenic hub in asthma, contributing to sustained inflammation and tissue remodeling.
    • Triggers such as allergens, viruses, and pollutants activate necroptosis in a cell-specific manner, leading to the release of DAMPs that amplify type 2 inflammation.
    • The asthmatic airway microenvironment is conducive to necroptosis due to recurrent exposure to triggers and oxidative stress.
    Interpretation:

    The review posits that necroptosis plays a critical role in translating environmental and immunological insults into chronic immune dysregulation and airway remodeling in asthma.

    Limitations:
    • Most insights are derived from preclinical models, which may not fully replicate human asthma pathology.
    • Species-specific differences exist in the regulation of necroptotic pathways.
    • Technical challenges in obtaining longitudinal human airway tissue limit dynamic assessments of necroptotic activity.
    Conclusion:

    Integrating necroptosis into the asthma pathophysiological network provides a unified framework for understanding disease mechanisms and potential therapeutic targets.

Original Source(s)

Related Content